63 related articles for article (PubMed ID: 19825960)
1. DNA ploidy cytometry testing for cervical cancer screening in China (DNACIC Trial): a prospective randomized, controlled trial.
Tong H; Shen R; Wang Z; Kan Y; Wang Y; Li F; Wang F; Yang J; Guo X;
Clin Cancer Res; 2009 Oct; 15(20):6438-45. PubMed ID: 19825960
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy compared with human papilloma virus testing (Hybrid Capture II) and conventional cervical cytology as a primary screening test for cervical high-grade lesions and cancer in 1555 patients with biopsy confirmation.
Guillaud M; Benedet JL; Cantor SB; Staerkel G; Follen M; MacAulay C
Cancer; 2006 Jul; 107(2):309-18. PubMed ID: 16773634
[TBL] [Abstract][Full Text] [Related]
3. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
4. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
[TBL] [Abstract][Full Text] [Related]
5. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.
Ronco G; Brezzi S; Carozzi F; Dalla Palma P; Giorgi-Rossi P; Minucci D; Naldoni C; Segnan N; Zappa M; Zorzi M; Cuzick J;
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S230-2. PubMed ID: 17822751
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus testing for primary screening of cervical cancer precursors.
Ratnam S; Franco EL; Ferenczy A
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):945-51. PubMed ID: 11008913
[TBL] [Abstract][Full Text] [Related]
7. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
8. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
[TBL] [Abstract][Full Text] [Related]
10. Adaptation of image cytometry methodology for DNA ploidy analysis of cervical epithelium samples: a pilot study.
Duarte CE; Carvalho CR; Silva-Filho AL
Taiwan J Obstet Gynecol; 2014 Jun; 53(2):227-31. PubMed ID: 25017273
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy cytometry testing for cervical cancer screening in China - letter.
Garner DM; Guillaud MD; MacAulay CE
Clin Cancer Res; 2010 Jul; 16(13):3517. PubMed ID: 20570931
[No Abstract] [Full Text] [Related]
12. Diagnostic and prognostic value of DNA cytometry in gynecologic cytology.
Böcking A; Chatelain R
Anal Quant Cytol Histol; 1989 Jun; 11(3):177-86. PubMed ID: 2663008
[TBL] [Abstract][Full Text] [Related]
13. DNA cytometry testing for cervical cancer screening: approaches and reporting standards for new technologies.
Colditz GA; Crowley J
Clin Cancer Res; 2011 Nov; 17(22):6971-2. PubMed ID: 21940755
[TBL] [Abstract][Full Text] [Related]
14. Effects of Information Technology-Based Two-Way Referral on Diagnosis and Management of Cervical Lesions: A Cluster-Controlled Trial in China.
Jin LM; Xu L; Xu J; Zhang XH; Zhang LL; Zhu LH; Yang HB; Zhang L; Yao Y; Feng H
Asia Pac J Public Health; 2018 Jul; 30(5):491-499. PubMed ID: 29992824
[TBL] [Abstract][Full Text] [Related]
15. [Implication of inverse-probability weighting method in the evaluation of diagnostic test with verification bias].
Kang L; Zhang S; Zhao F; Qiao Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):329-32. PubMed ID: 24831638
[TBL] [Abstract][Full Text] [Related]
16. Alleviating psychological distress associated with a positive cervical cancer screening result: a randomized control trial.
Isaka Y; Hori A; Tanaka R; Ichikawa M
BMC Womens Health; 2021 Feb; 21(1):64. PubMed ID: 33579257
[TBL] [Abstract][Full Text] [Related]
17. Clinical application of DNA ploidy to cervical cancer screening: A review.
Garner D
World J Clin Oncol; 2014 Dec; 5(5):931-65. PubMed ID: 25493231
[TBL] [Abstract][Full Text] [Related]
18. Comparing new and old screening tests when a reference procedure cannot be performed on all screenees. Example of automated cytometry for early detection of cervical cancer.
Schatzkin A; Connor RJ; Taylor PR; Bunnag B
Am J Epidemiol; 1987 Apr; 125(4):672-8. PubMed ID: 3826045
[TBL] [Abstract][Full Text] [Related]
19. Discovering asymptomatic non-precancerous lesions with cervical cytologic mass-screening campaigns: is it a benefit or a cost?
Almasio P; Chiappa L; Duca P; Turolla E
Tumori; 1985 Jun; 71(3):219-23. PubMed ID: 3927542
[TBL] [Abstract][Full Text] [Related]
20. Quantitative image analysis and flow cytometry can improve early detection of cancer.
Deleener A; Gunst J; Vanderkerken K; Kirsch-Volders M
Recent Results Cancer Res; 1991; 122():42-51. PubMed ID: 1947414
[No Abstract] [Full Text] [Related]
[Next] [New Search]
